IPC-klasse
Fullmektig i Norge:
Org.nummer: 982702887
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2016.06.30, US 201662357151 P
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 2 December 2016 (2016-12-02), GERTZ MORIE A ET AL: "NEOD001 Demonstrates Organ Biomarker Responses in Patients with Light Chain Amyloidosis and Persistent Organ Dysfunction: Results from the Expansion Cohort of a Phase 1/2 Study", XP002775103, Database accession no. PREV201700298547 (B1)
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 2 December 2016 (2016-12-02), LIEDTKE MICHAELA ET AL: "Organ Biomarker Responses in Patients with Light Chain Amyloidosis Treated with NEOD001 Are Independent of Previous Hematologic Response", XP002775102, Database accession no. PREV201700298550 & LIEDTKE MICHAELA ET AL: "Organ Biomarker Responses in Patients with Light Chain Amyloidosis Treated with NEOD001 Are Independent of Previous Hematologic Response", BLOOD, vol. 128, no. 22, 2 December 2016 (2016-12-02), page 647, & 58TH ANNUAL MEETING AND EXPOSITION OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; SAN DIEGO, CA, USA; DECEMBER 03 -06, 2016 ISSN: 0006-4971(print) (B1)
WO-A2-2009/086539 (B1)
MORIE A. GERTZ ET AL: "First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction", JOURNAL OF CLINICAL ONCOLOGY, vol. 34, no. 10, 1 April 2016 (2016-04-01) , pages 1097-1103, XP055418883, US ISSN: 0732-183X, DOI: 10.1200/JCO.2015.63.6530 (B1)
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; December 2015 (2015-12), ZAGO WAGNER ET AL: "NEOD001 Specifically Binds Aggregated Light Chain Infiltrates in Multiple Organs from Patients with AL Amyloidosis and Promotes Phagocytic Clearance of AL Aggregates in Vitro", XP002775104, Database accession no. PREV201600269090 & ZAGO WAGNER ET AL: "NEOD001 Specifically Binds Aggregated Light Chain Infiltrates in Multiple Organs from Patients with AL Amyloidosis and Promotes Phagocytic Clearance of AL Aggregates in Vitro", BLOOD, vol. 126, no. 23, December 2015 (2015-12), & 57TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ORLANDO, FL, USA; DECEMBER 05 -08, 2015 ISSN: 0006-4971(print) (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210) (PTEP3478713)
|
Innkommende
Korrespondanse (Hovedbrev inn)
|
Innkommende
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 8. avg. år (EP) | 2024.06.27 | 3320 | COMPUTER PACKAGES INC. | Betalt og godkjent |
Årsavgift 7. avg. år (EP) | 2023.06.28 | 2200 | COMPUTER PACKAGES INC. | Betalt og godkjent |
Årsavgift 6. avg. år (EP) | 2022.07.27 | 2000 | COMPUTER PACKAGES INC. | Betalt og godkjent |
32208030 expand_more expand_less | 2022.06.09 | 5500 | ZACCO NORWAY AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|